Robert Flavell, MD, PhD
|School||UCSF School of Medicine|
|Address||Wharf St. Building|
San Francisco CA 94158
|Department of Defense Prostate Cancer ||2016||Research Program Physician Research Training Grant|
|University of California, San Francisco ||2016||Runner up, Surbeck Scholar Award|
|Radiology Society of North America (RSNA) ||2015||Certificate of Merit|
|Association of University Radiologists / American College of Radiology ||2015||Research Scholar Program |
|Radiology Society of North America (RSNA) ||2014||Certificate of Merit|
|University of California, San Francisco Catalyst Program ||2014||Catalyst Consultation Award |
|National Institute of Biomedical Imaging and Bioengineering (NIBIB)||2014||T32 Training Grant |
|American Roentgen Ray Society||2013||Introduction to Academic Radiology Program |
Robert Flavell, MD, PhD, is an Assistant Professor in the Nuclear Medicine subspecialty in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He received his medical degree from Weill Cornell Medical College, and his PhD from the Rockefeller University as part of the Tri-Institutional MD PhD program. He completed his one-year internship at the Memorial SloanKettering Cancer Center in New York. Dr. Flavell completed a four-year diagnostic radiology residency at the University of California, San Francisco, where he also finished a Nuclear Medicine fellowship. In June 2016. he joined the faculty as an Assistant Professor in Residence.
Dr. Flavell’s laboratory focuses on the development of new molecular imaging tools for better understanding of disease progression in patients with prostate and other cancers. One area of interest is the relationship between acidic interstitial pH and disease progression. Solid tumors are poorly perfused and secrete acids into the adjacent interstitium, resulting in a pH which is mildly acidic, typically ranging from 6.5 – 7.0. This property has been associated with high-grade malignancy, local invasion, and metastasis in animal models. Therefore, it would be desirable to have a method which could be used in patients for monitoring tissue pH. Therefore, one focus of Dr. Flavell’s research is developing methods of imaging acidic interstitial pH with potential for clinical translation. Specifically, two methods are being developed, one of which permits whole body evaluation of areas of acidic pH using positron emission tomography (PET) imaging, and one method which permits quantitative, local determination of interstitial pH based on hyperpolarized 13C magnetic resonance spectroscopy (HP-MRS). The PET method is based on pro-drug glycosylamine derivatives of the commonly used oncologic tracer, [18F]FDG, termed [18F]FDG amines, which are blocked with an acid-labile protecting group. When exposed to the mildly acidic pH present in the interstitium of a solid tumor, the caging group decomposes, liberating native [18F]FDG, which is subsequently absorbed by the adjacent cancer cell (Flavell R.R. et al., Bioconjugate Chem., 2016). The HP-MRS method is based on the administration of a 13C labeled probe which has a predictable change in its chemical shift based on pH. By comparison to a standard curve, quantitative pH measurements can be obtained (Flavell R.R. et al. Chem. Comm. 2015). These techniques are being optimized and ongoing directions include application in animal models, with the long term goal of clinical translation. Other areas of developing interest in the laboratory include techniques for imaging of metals in the microenvironment, and imaging of a metabolic signature associated with immune activation.
Novel radiotracer development, oncologic imaging, PET imaging, hyperpolarized 13C magnetic resonance imaging
Radiology, molecular imaging, PET imaging, prostate cancer, nuclear medicine, radiochemistry, hyperpolarized 13C magnetic resonance imaging
Education and Training:
• Medical School: Weill Cornell Medical College, New York
• PhD: The Rockefeller University, New York
• Internship: Memorial Sloan-Kettering Cancer Center, New York
• Residency: University of California, San Francisco
• Fellowship: University of California, San Francisco – Nuclear Medicine
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.